About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Y
The Gut Microbiota, Hepatic Inflamation, and Carcinogenesis
By
Yu-Jui Yvonne Wan
0 views
December 13, 2022
Comments
0
Login to view comments.
Click here to Login
Featured Video
05:30
Ardelyx
Asking the Right Questions: A Key Step in Treating IBS-C
Feat.
J. Ackerman
Featured Video
06:42
Ardelyx
Clinical Experience With an IBS-C Treatment Option
Feat.
J. Shah
Recommended
AUTOPLAY
ON
18:46
Houston Methodist Hospital
MAFLD: What Is It?
Feat.
D. Victor
43:23
MedNews Week
Best Practices In Managing NAFLD / NASH
Feat.
D. Bernstein
58:00
West Virginia State Rheumatology Society
2022 Updates on the Management of Lupus Nephritis
Feat.
M. Petri
32:04
Douglas Drossman
Neuromodulators: Making the Right Choice for Your Patient
38:47
UPMC
The Fatty Liver Disease Epidemic
Feat.
M. Klinge
19:50
Stanford Medicine
Microbiome Screening in 2024: Ready For Prime Time?
Feat.
S. Spencer
49:14
Scripps Health
Using Resmetirom (THR-β Agonist) in Your Practice for MASH
Feat.
J. Gutierrez
48:59
Northwestern Medicine Gastroenterology
Cutting Edge Diagnostics and Treatment for NAFLD
Feat.
M. E. Rinella,
L. Van Wagner
27:35
Yale School of Medicine
Fatty Liver Disease: When to Refer?
25:53
Houston Methodist Hospital
Non-Alcoholic Fatty Liver Disease: Where Are We in 2023?
Feat.
N. Gunn
24:30
Scripps Health
Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease
Feat.
J. Au
22:23
Pennsylvania Society of Gastroenterology
Updates on Management of NASH
Feat.
T. Singh
31:41
LearnSkin
Acne, Rosacea, and Hidradenitis Suppurativa: Diagnosis and Management
Feat.
R. Sivamani
23:28
ACG 2023 Conference Coverage
Moderation of the Microbiome and C. difficile Infection: Have We Fin…
Feat.
P. Feuerstadt
23:50
Stanford Medicine
Debate: Horizons for Effective Microbial Therapeutics for GI Disease…
Feat.
S. Spencer,
A. Gabrielle Cheng
60:40
Scripps Health
Primary Care Management of Chronic Liver Disease
Feat.
J. Gutierrez
22:31
University of California, Irvine (UCI) Health 14th Annual Orange County Symposium for Cardiovascular Disease Prevention
Non-Alcoholic Fatty Liver Disease and Cardiovascular Risks: A Scient…
Feat.
P. Duell
27:34
Cleveland Clinic Neurological Institute
Gut-Brain Axis & Migraine
Feat.
S. Biswas
18:02
13th Orange County Symposium for Cardiovascular Disease Prevention
The Gut Microbiome: Friend or Foe?
Feat.
R. Greenfield
26:11
Scripps Health
New Treatments of Nonalcoholic Steatohepatitis (NASH): An Update on …
Feat.
J. Frias
